Home
Abstract
Abstract Submission
My Abstract(s)
Pre-Order Mascot
Dashboard
Submission Status
Submitted
Abstract Submission
Abstract Title
Rare concurrence of papillary thyroid carcinoma and ectopic atypical parathyroid tumor in a patient with persistent hypercalcemia
Presentation Type
Oral Presentation
Type Reference
Clinical Case
Abstract Category
Thyroid
Author's Information
Number of Authors (including submitting/presenting author) *
5
No more than 15 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Co-author 1
Chi-Peing Miao hellowping@naver.com Mackay Memorial Hospital Internal Medicine Taipei Taiwan *
Co-author 2
Chia-Ying Chu poohlover0517@gmail.com Mackay Memorial Hospital Pathology Taitung Taiwan -
Co-author 3
Yu-Huie Yang b101090099@gmail.com Mackay Memorial Hospital Surgery Taitung Taiwan -
Co-author 4
Shou Sen Huang hsosoyfl@gmail.com Mackay Memorial Hospital Surgery Taitung Taiwan -
Co-author 5
YH Zeng starrydouchain@yahoo.com.tw Mackay Memorial Hospital Internal Medicine Taitung Taiwan -
Co-author 6
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
Abstract Content
Background and aims *
Papillary thyroid carcinoma (PTC) is the predominant thyroid malignancy, whereas atypical parathyroid tumor (APT) is rare, and ectopic localization further complicates detection. Persistent hypercalcemia with “normal-range” PTH can mask parathyroid pathology. We report a case of concurrent PTC and ectopic APT presenting with postoperative hypercalcemia, highlighting diagnostic pitfalls.
Methods *
Single-patient case report with retrospective review of clinical data, biochemistry, imaging (neck ultrasound, fine-needle aspiration, sestamibi SPECT/CT, chest CT), operations (total thyroidectomy, bilateral cervical parathyroidectomy, and subsequent percutaneous endoscopic mediastinal excision), and histopathology including immunohistochemistry.
Results *
A 46-year-old woman with type 2 diabetes presented with polydipsia and intermittent headaches. Initial studies showed hypercalcemia (11.7 mg/dL), normal phosphate (2.9 mg/dL), inappropriately normal iPTH (38.6 pg/mL), 24-h urine calcium 358 mg/day, and 25(OH)D 25 ng/mL. Thyroid ultrasound revealed nodules; FNA was suspicious for PTC. She underwent total thyroidectomy and bilateral parathyroidectomy; pathology confirmed classic PTC without metastasis. Postoperatively, hypercalcemia persisted (11.6 mg/dL) with non-suppressed iPTH (22.2 pg/mL). Delayed sestamibi showed a subtle focus in the superior mediastinum; chest CT identified a 1.8cm paraesophageal mass. Percutaneous endoscopic excision achieved biochemical cure (calcium 8.9 mg/dL; iPTH 7.71 pg/mL). Histology demonstrated an atypical parathyroid tumor with a thick fibrous capsule and chief-cell morphology; immunostains were positive for chromogranin A, GATA-3, and PTH, confirming parathyroid origin. The patient was discharged on postoperative day 5 and entered routine follow-up.
Conclusions *
In patients with persistent hypercalcemia after thyroid/parathyroid surgery, a “normal” PTH is physiologically inappropriate and should prompt evaluation for dual pathology and ectopic parathyroid disease. Subtle or focal scintigraphic uptake warrants targeted cross-sectional imaging (e.g., SPECT/CT, 4D-CT, or ^18F-fluorocholine PET/CT). Minimally invasive mediastinal excision can be curative.
Keyword(s)
Papillary thyroid carcinoma, atypical parathyroid tumor, ectopic atypical parathyroid tumor.
Figure 1
https://storage.unitedwebnetwork.com/files/1305/b2bc53e1f32aa7abd29164a2ae808369.png
Figure 1 Caption
A 1.8cm heterogenous enhancing mass at the posterior mediastinum compressing the esophagus, compatible with ectopic parathyroid gland.
Total Word Count
290
Presenting Author First Name
Chi-Peing
Presenting Author Last Name
Miao
Presenting Author Email
hellowping@naver.com
Country (Internal Use)
Presentation Details
Session
Oral Presentation 3: Thyroid Oncology & Cardiovascular Complications
Date
Mar. 21 (Sat.)
Time
10:38 - 10:47
Presentation Order
03